Lattouf R, Younes R, Lutomski D, Naaman N, Godeau G, Senni K, Changotade S
Our providers will help determine which option best fits your goals, health history, and lifestyle
When combined with baseline metabolic biomarkers (fasting glucose, insulin, lipid profile, inflammatory markers), genetic insights from the Precision Peptide test can help your provider evaluate whether GLP-1 therapy aligns with your individual risk profile and comorbidity burden
Our data suggests that with Omadas support, patients are able to persist on their medications to achieve meaningful weight loss, which improves outcomes and protects ROI
It was meant to rule out deficiency, but the result points the other direction